ERRATUM article

Front. Pharmacol., 27 January 2025

Sec. Ethnopharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1557520

Erratum: A randomized double-blind active-controlled clinical trial on the efficacy of topical basil (Ocimum basilicum) oil in knee osteoarthritis

This article is an erratum on:

  1. A randomized double-blind active-controlled clinical trial on the efficacy of topical basil (Ocimum basilicum) oil in knee osteoarthritis

    1. Read original article
Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
A randomized double-blind active-controlled clinical trial on the efficacy of topical basil (Ocimum basilicum) oil in knee osteoarthritis

by Askari A, Hasheminasab FS, Sadeghpour O, Naghizadehd MM, Ravansalar SA, Iraji A and Hashempur MH (2024). Front. Pharmacol. 15:1377527. doi: 10.3389/fphar.2024.1377527

Due to a production error, “Alireza Askari” and “Fatemeh Sadat Hasheminasab” were not recognized as co-first authors. The corrected author list with the shared first authorship tag appears below. The publisher apologizes for this mistake.

“Alireza Askari1†, Fatemeh Sadat Hasheminasab2,3†, Omid Sadeghpour4, Mohammad Mehdi Naghizadehd5, Seyed Ali Ravansalar6, Aida Iraji7 and Mohammad Hashem Hashempur7*.

†These authors share first authorship.”

The original version of this article has been updated.

Keywords: osteoarthritis, herbal medicine, traditional Persian medicine, basil, Ocimum basilicum

Citation: Frontiers Production Office (2025) Erratum: A randomized double-blind active-controlled clinical trial on the efficacy of topical basil (Ocimum basilicum) oil in knee osteoarthritis. Front. Pharmacol. 16:1557520. doi: 10.3389/fphar.2025.1557520

Received: 08 January 2025; Accepted: 08 January 2025;
Published: 27 January 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.